MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sophiris Bio Company Profile (NASDAQ:SPHS)

Consensus Ratings for Sophiris Bio (NASDAQ:SPHS) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.00 (300.00% upside)

Analysts' Ratings History for Sophiris Bio (NASDAQ:SPHS)
Show:
DateFirmActionRatingPrice TargetActions
3/24/2016Maxim GroupReiterated RatingBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Stifel NicolausDowngradeBuy -> Hold$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2014Leerink SwannInitiated CoverageOutperform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha